Genetic susceptibility and immune-mediated destruction in beryllium-induced disease

Trends in Immunology

Volumn 26, Issue 10, 2005, Pages 543-549

  Fontenot, Andrew P ^a   Maier, Lisa A ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BERYLLIUM; COBALT; COPPER; GLUTAMIC ACID; HLA DP ANTIGEN; METAL; NICKEL; T LYMPHOCYTE RECEPTOR;

ALLELE; ANTIGEN PRESENTATION; AUTOIMMUNE DISEASE; BERYLLIOSIS; BETA CHAIN; BLOOD; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GRANULOMATOUS INFLAMMATION; HUMAN; HYPERSENSITIVITY; IMMUNE MEDIATED INJURY; LUNG; MOLECULAR RECOGNITION; OCCUPATIONAL EXPOSURE; PNEUMONIA; REVIEW; T LYMPHOCYTE; WORKER; WORKPLACE;

BERYLLIOSIS; BERYLLIUM; CD4-POSITIVE T-LYMPHOCYTES; CHRONIC DISEASE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNIZATION; PROTEIN STRUCTURE, SECONDARY;

EID: 24744445780     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2005.08.004     Document Type: Review

References (71)

1. L.S. Newman, and L.A. Maier Beryllium disease M.I. Schwarz T.E. King Jr Interstitial Lung Disease 2003 B.C. Decker Inc 435 451
2. B.L. Scott Potential binding models of beryllium with class II major histocompatibility complex HLA-DP: a combined theoretical and structural database study J. Inorg. Biochem. 94 2003 5 13
3. H. Weber, and W.E. Engelhardt Investigation of dust arising out of beryllium extraction Gewerbehyg Unfallverhuet 10 1933 41
4. I. Gelman Poisoning by vapors of beryllium oxyfluoride J. Ind. Hyg. Toxicol. 18 1936 371 399
5. M. Berkovits, and B. Izreal Changes in the lungs by beryllium oxyfluoride Klin. Med. (Mosk.) 18 1940 117 122
6. H.L. Hardy, and I.R. Tabershaw Delayed chemical pneumonitis in workers exposed to beryllium compounds J. Ind. Hyg. Toxicol. 28 1946 197 211
7. K. Kreiss Screening blood test identifies subclinical beryllium disease J. Occup. Med. 31 1989 603 608
8. K. Kreiss Beryllium disease screening in the ceramics industry: blood test performance and exposure-disease relations J. Occup. Med. 35 1993 267 274
9. K. Kreiss Epidemiology of beryllium sensitization and disease in nuclear workers Am. Rev. Respir. Dis. 148 1993 985 991
10. 3 Am. J. Ind. Med. 30 1996 16 25
11. P.K. Henneberger Beryllium sensitization and disease among long-term and short-term workers in a beryllium ceramics plant Int. Arch. Occup. Environ. Health 74 2001 167 176
12. L.S. Newman Beryllium sensitization progresses to chronic beryllium disease: a longitudinal study of disease risk Am. J. Respir. Crit. Care Med. 171 2004 54 60
13. A.P. Fontenot Chronic beryllium disease: T cell recognition of a metal presented by HLA-DP Clin. Immunol. 100 2001 4 14
14. A.P. Fontenot, and B.L. Kotzin Chronic beryllium disease: immune-mediated destruction with implications for organ-specific autoimmunity Tissue Antigens 62 2003 449 458
15. L.S. Newman Pathologic and immunologic alterations in early stages of beryllium disease: re-examination of disease definition and natural history Am. Rev. Respir. Dis. 139 1989 1479 1486
16. L.S. Newman, and K. Kreiss Nonoccupational beryllium disease masquerading as sarcoidosis: identification by blood lymphocyte proliferation response to beryllium Am. Rev. Respir. Dis. 145 1992 1212 1214
17. L.S. Newman Sarcoidosis N. Engl. J. Med. 336 1997 1224 1234
18. W.J. Williams, and D. Kelland New aid for diagnosing chronic beryllium disease (CBD): laser ion mass analysis (LIMA) J. Clin. Pathol. 39 1986 900 901
19. W.J. Williams, and E.R. Wallach Laser microprobe mass spectrometry (LAMMS) analysis of beryllium, sarcoidosis, and other granulomatous diseases Sarcoidosis 6 1989 111 117
20. L.S. Newman The natural history of beryllium sensitization and chronic beryllium disease Environ. Health Perspect. 104S 1996 937 943
21. W.J. Williams United Kingdom beryllium registry: mortality and autopsy study Environ. Health Perspect. 104S 1996 949 951
22. M.D. Rossman Proliferative response of bronchoalveolar lymphocytes to beryllium Ann. Intern. Med. 108 1988 687 693
23. C. Saltini Maintenance of alveolitis in patients with chronic beryllium disease by beryllium-specific helper T cells N. Engl. J. Med. 320 1989 1103 1109
24. C. Saltini Biased accumulation of T lymphocytes with "memory"- type CD45 leukocyte common antigen gene expression on the epithelial surface of the human lung J. Exp. Med. 171 1990 1123 1140
25. A.P. Fontenot Identification of pathogenic T cells in patients with beryllium-induced lung disease J. Immunol. 163 1999 1019 1026
26. A.P. Fontenot Expansions of T-cell subsets expressing particular T cell receptor variable regions in chronic beryllium disease Am. J. Respir. Cell Mol. Biol. 18 1998 581 589
27. A.P. Fontenot Beryllium skin patch testing to analyze T cell stimulation and granulomatous inflammation in the lung J. Immunol. 168 2002 3627 3634
28. + T cells in patients with chronic beryllium disease J. Clin. Invest. 110 2002 1473 1482
29. + T cells in blood determines proliferative response. J. Clin. Invest. (in press)
30. S.S. Tinkle Beryllium induces IL-2 and IFN-γ in berylliosis J. Immunol. 158 1997 518 526
31. + T cells in patients with beryllium-induced disease J. Allergy Clin. Immunol. 115 2005 1036 1042
32. P. Marrack, and J. Kappler The T cell receptor Science 238 1987 1073 1078
33. M.M. Davis, and P.J. Bjorkman T-cell antigen receptor genes and T-cell recognition Nature 334 1988 395 402
34. T.P. Arstila A direct estimate of the human αβ T cell receptor diversity Science 286 1999 958 961
35. G. Lombardi HLA-DP allele-specific T cell responses to beryllium account for DP-associated susceptibility to chronic beryllium disease J. Immunol. 166 2001 3549 3555
36. + T cell clones in the synovial fluid of patients with rheumatoid arthritis J. Immunol. 161 1998 4428 4436
37. + T cells in bronchoalveolar lavage fluid and peripheral blood of sarcoidosis patients Proc. Natl. Acad. Sci. U. S. A. 91 1994 4965 4969
38. + T lymphocytes in bronchoalveolar lavage fluid from sarcoidosis patients correlates with HLA-DR3 Eur. J. Immunol. 22 1992 129 135
39. + sarcoidosis patients Mol. Med. 1 1995 287 296
40. A.H. Sharpe, and G.J. Freeman The B7-CD28 superfamily Nat. Rev. Immunol. 2 2002 116 126
41. J.A. Bluestone New perspectives of CD28-B7-mediated T cell costimulation Immunity 2 1995 555 559
42. F.A. Harding CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones Nature 356 1992 607 609
43. R.H. Schwartz A cell culture model for T lymphocyte clonal anergy Science 248 1990 1349 1356
44. M. Croft Naive versus memory CD4 T cell response to antigen. Memory cells are less dependent on accessory cell costimulation and can respond to many antigen-presenting cell types including resting B cells J. Immunol. 152 1994 2675 2685
45. + T cells J. Clin. Invest. 112 2003 776 784
46. Y.K. Chou Activation pathways implicate anti-HLA-DP and anti-LFA-1 antibodies as lead candidates for intervention in chronic berylliosis J. Immunol. 174 2005 4316 4324
47. L. Richeldi HLA-DPB1 glutamate 69: a genetic marker of beryllium disease Science 262 1993 242 244
48. L. Richeldi Interaction of genetic and exposure factors in the prevalence of berylliosis Am. J. Ind. Med. 32 1997 337 340
49. Z. Wang Differential susceptibilities to chronic beryllium disease contributed by different Glu69 HLA-DPB1 and -DPA1 alleles J. Immunol. 163 1999 1647 1653
50. M.D. Rossman Human leukocyte antigen class II amino acid epitopes: susceptibility and progression markers for beryllium hypersensitivity Am. J. Respir. Crit. Care Med. 165 2002 788 794
51. L.A. Maier Influence of MHC class II in susceptibility to beryllium sensitization and chronic beryllium disease J. Immunol. 171 2003 6910 6918
52. 69 and chronic beryllium disease and beryllium sensitization Am. J. Ind. Med. 46 2004 95 103
53. Z. Wang Beryllium sensitivity is linked to HLA-DP genotype Toxicology 165 2001 27 38
54. C. Saltini Major histocompatibility locus genetic markers of beryllium sensitization and disease Eur. Respir. J. 18 2001 677 684
55. L.A. Maier High beryllium-stimulated TNF-α is associated with the -308 TNF-α promoter polymorphism and with clinical severity in chronic beryllium disease Am. J. Respir. Crit. Care Med. 164 2001 1192 1199
56. + T cells underlies disease susceptibility HLA-DP alleles in chronic beryllium disease Proc. Natl. Acad. Sci. U. S. A. 97 2000 12717 12722
57. F. Berretta Detailed analysis of the effects of Glu/Lys β69 human leukocyte antigen-DP polymorphism on peptide-binding specificity Tissue Antigens 62 2003 459 471
58. M. Amicosante Beryllium binding to HLA-DP molecule carrying the marker of susceptibility to berylliosis glutamate β69 Hum. Immunol. 62 2001 686 693
59. J.E. Penzotti Use of T cell receptor/HLA-DRB1*04 molecular modeling to predict site-specific interactions for the DR shared epitope associated with rheumatoid arthritis Arthritis Rheum. 40 1997 1316 1326
60. L. Budinger, and M. Hertl Immunologic mechanisms in hypersensitivity reactions to metal ions: an overview Allergy 55 2000 108 115
61. C. Moulon Characterization of processing requirements and metal cross-reactivities in T cell clones from patients with allergic contact dermatitis to nickel Eur. J. Immunol. 25 1995 3308 3315
62. L. Emtestam HLA-DR, -DQ and -DP alleles in nickel, chromium, and/or cobalt-sensitive individuals: genomic analysis based on restriction fragment length polymorphisms J. Invest. Dermatol. 100 1993 271 274
63. F. Sinigaglia Isolation and characterization of Ni-specific T cell clones from patients with Ni-contact dermatitis J. Immunol. 135 1985 3929 3932
64. J. Vollmer Functional expression and analysis of a human HLA-DQ restricted, nickel-reactive T cell receptor in mouse hybridoma cells J. Invest. Dermatol. 113 1999 175 181
65. F. Sinigaglia The molecular basis of metal recognition by T cells J. Invest. Dermatol. 102 1994 398 401
66. P. Romagnoli Selective interaction of Ni with an MHC-bound peptide EMBO J. 10 1991 1303 1306
67. ++ reactive human T cell clone J. Exp. Med. 197 2003 567 574
68. I. Potolicchio Susceptibility to hard metal lung disease is strongly associated with the presence of glutamate 69 in HLA-DPβ chain Eur. J. Immunol. 27 1997 2741 2743
69. I. Potolicchio HLA-DP molecules bind cobalt: a possible explanation for the genetic association with hard metal disease Eur. J. Immunol. 29 1999 2140 2147
70. F. Sallusto Two subsets of memory T lymphocytes with distinct homing potentials and effector functions Nature 401 1999 708 712
71. B.L. Kotzin, and J. Kappler Targeting the TCR in rheumatoid arthritis Arthritis Rheum. 41 1998 1907 1929